CLINICAL_TRIALS
trial_result
· 2014-12-31
Clinical Trial Update: Sorafenib. ICORG 06-41, V4 [Phase 2]
Summary
Phase 2 trial ICORG 06-41 evaluating Sorafenib in esophageal and gastric cancers has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cancer Trials Ireland | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED